← Leaderboards
Anne M Connolly
Washington University
$2,999,927
Attributed
$2,999,927
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,999,927 · 3
By mechanism
U01$2,998,564 · 1
M01$1,363 · 2
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Susan R. Wente$12,375,699
- Matthew J Walter$8,261,626
- Jeffrey H Miner$20,654,870
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelResearch PersonnelUnited States National Institutes Of HealthGenesSeveritiesChildhoodBiological MarkersBiceps Brachii MuscleAffectBreathingCapnographyCarbon DioxideCaregiversCertificationAdvocacy5 Year OldChild DevelopmentChildBirthBlindedClinical Outcome AssessmentClinical Research SiteClinical Trial ReadinessChest
Grant awards (5)
Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 Mutations$857,429
U01 · FY2025 · NS · contact PI
Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 Mutations$845,606
U01 · FY2024 · NS · contact PI
Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 Mutations$1,295,529
U01 · FY2023 · NS · contact PI
STUDY OF SODIUM PHENYLBUTYRATE IN PEDIATRICS SUBJECTS WITH TYPE II/III SMA$541
M01 · FY2007 · RR · contact PI
RILUTEK IN THE TREATMENT OF INFANTS WITH SMA$822
M01 · FY2005 · RR